 | Analysts Anticipate Aclaris Therapeutics, Inc. (NASDAQ:ACRS) to Announce -$0.36 Earnings Per Share
americanbankingnews.com - January 27 at 9:34 AM |
| Aclaris Therapeutics (NASDAQ:ACRS) Sets New 12-Month Low at $9.32
americanbankingnews.com - January 24 at 11:12 AM |
| Aclaris Therapeutics (NASDAQ:ACRS) Shares Gap Down to $10.14
americanbankingnews.com - January 19 at 12:01 PM |
| Aclaris Therapeutics (NASDAQ:ACRS) Hits New 1-Year Low at $10.08
americanbankingnews.com - January 18 at 5:12 PM |
 | Bed Bath & Beyond, Orphazyme lead postmarket gainers; Gogo, Biogen among losers
seekingalpha.com - January 13 at 6:33 PM |
 | The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
msn.com - January 12 at 12:21 PM |
| Aclaris Therapeutics (NASDAQ:ACRS) Shares Gap Down to $12.86
americanbankingnews.com - January 12 at 11:54 AM |
| Aclaris falls on the exit of medical chief
seekingalpha.com - January 11 at 7:07 PM |
 | Aclaris Therapeutics Provides R&D Update
finance.yahoo.com - January 11 at 7:07 PM |
| Aclaris Therapeutics (NASDAQ:ACRS) Sees Unusually-High Trading Volume
americanbankingnews.com - January 11 at 1:28 PM |
| Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference
finance.yahoo.com - December 27 at 7:48 AM |
|
| Is Aclaris Therapeutics, Inc. (ACRS) Going to Burn These Hedge Funds?
finance.yahoo.com - December 8 at 12:31 PM |
| Here's Why We're Not Too Worried About Aclaris Therapeutics' (NASDAQ:ACRS) Cash Burn Situation
finance.yahoo.com - November 23 at 8:55 AM |
| Aclaris Therapeutics Announces Proposed Settlement and Settlement Hearing of Stockholder Derivative Action
finance.yahoo.com - August 27 at 8:24 PM |
 | Looking into Aclaris Therapeutics's Return on Capital Employed
benzinga.com - August 27 at 8:24 PM |
 | Should You Buy Aclaris Therapeutics (ACRS) Ahead of Earnings?
nasdaq.com - August 5 at 12:59 PM |
| BRIEF-Aclaris Therapeutics Reports Second Quarter 2021 Financial Results
msn.com - August 5 at 7:58 AM |
| Aclaris Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate Update
finance.yahoo.com - August 5 at 7:58 AM |
| Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
finance.yahoo.com - July 30 at 7:36 PM |
| Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021
finance.yahoo.com - July 8 at 9:33 AM |
 | Aclaris Therapeutics prices $125M public stock offering
bizjournals.com - June 10 at 2:23 PM |
 | Aclaris Therapeutics Down 5% After Plans for Stock Offering
marketwatch.com - June 9 at 6:36 PM |
| Aclaris (ACRS) Announces Data on Atopic Dermatitis Candidate
finance.yahoo.com - June 9 at 1:35 PM |
| Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Aclaris Therapeutics Shares Plunge
benzinga.com - June 8 at 7:09 PM |
| Aclaris' ATI-1777 Aces Atopic Dermatitis Trial with Minimal Systemic Exposure
finance.yahoo.com - June 8 at 2:08 PM |
| BRIEF-Aclaris Therapeutics Announces Positive Preliminary Topline Data From Phase 2A Trial Of ATI-1777 For Moderate To Severe Atopic Dermatitis
msn.com - June 8 at 9:07 AM |
| Aclaris Therapeutics Announces Positive Preliminary Topline Data from Phase 2a Trial of ATI-1777 for Moderate to Severe Atopic Dermatitis
finance.yahoo.com - June 8 at 9:07 AM |
| What Type Of Shareholders Make Up Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) Share Registry?
finance.yahoo.com - May 18 at 7:23 AM |
| Aclaris Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 17 at 9:52 AM |
| Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 7 at 12:44 PM |
| Aclaris Therapeutics Reports First Quarter 2021 Financial Results and Provides a Corporate Update
finance.yahoo.com - May 7 at 7:44 AM |
 | Aclaris Therapeutics Inc (ACRS) President and CEO Neal Walker Sold $805,200 of Shares
uk.finance.yahoo.com - April 27 at 6:57 AM |
| Is ACRS Stock A Buy or Sell?
finance.yahoo.com - April 26 at 7:23 AM |
| Aclaris Therapeutics Stock Appears To Be Significantly Overvalued
finance.yahoo.com - April 1 at 8:23 AM |
|
| Aclaris Therapeutics Completes Enrollment in its Phase 2a Clinical Trial of ATI-1777 for Moderate to Severe Atopic Dermatitis
finance.yahoo.com - March 15 at 8:29 AM |
| Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
finance.yahoo.com - February 25 at 8:29 AM |
| Aclaris Therapeutics to Participate in Upcoming Investor Conferences
finance.yahoo.com - February 22 at 9:00 AM |
| Aclaris Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 10 at 9:06 AM |
| Gaining Ground After A Tough Couple Of Weeks
finance.yahoo.com - January 25 at 7:34 PM |
| Aclaris aims to raise $96 million through stock offering after shares soar
bizjournals.com - January 20 at 9:29 PM |
| Aclaris Therapeutics' stock jumps on positive data for drug developed by St. Louis-based unit
bizjournals.com - January 20 at 4:22 PM |
| How High Is the Blue Sky for Aclaris Stock? Analyst Weighs In
finance.yahoo.com - January 20 at 4:21 PM |
| Aclaris Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 20 at 11:21 AM |
| Aclaris (ACRS) Up on Preliminary Data for MK2 Inhibitor in RA
finance.yahoo.com - January 20 at 11:21 AM |
| Aclaris Explodes 220% On ‘Positive Data’ From Rheumatoid Arthritis Trial
finance.yahoo.com - January 20 at 6:20 AM |
 | ACRS Soars On RA Trial Data, BHVN Disappoints In Alzheimer's Trial, GRTS Joins COVID-19 Vaccine Race
markets.businessinsider.com - January 20 at 1:20 AM |
| Is Aclaris Therapeutics a Stock to Buy After Nearly 200% Run-Up and Now This?
msn.com - January 19 at 8:20 PM |
| Aclaris Therapeutics' stock skyrockets 220% on positive data for potential arthritis treatment
bizjournals.com - January 19 at 8:20 PM |
| Aclaris Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 19 at 8:20 PM |
| Aclaris Triples After Progress in Rheumatoid Arthritis Drug Trial
finance.yahoo.com - January 19 at 8:20 PM |
